- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
5 Injectable Insights
In 2020, injectables saw improvements in consultations, combination therapy, and more.
As injectables continue to improve both in use and product, 2020 brought an increased demand for injectables during the COVID-19 pandemic, pricing changes and the struggle between quality over price, the idea of threadlift as injectable, attention to the injectable consultation, and combination therapies with injectables and energy devices.
Demand for Injectables Grows During COVID-19
The pandemic has ushered in new and unexpected injectable trends plus enhanced protocols for ensuring physician and patient safety.
Changing the Injectable Pricing Game
Dustin Sjuts, CCO, Revance, says the company aims to elevate the patient dermal filler experience by emphasizing experience and quality over price.
It's a paradigm shift for the threadlift, which offers subtle tissue adjustment and biostimulation to generate natural results that last beyond the life of the threads themselves.
Improving the Injectable Consultation
Dr. Vince Bertucci offers tips to improve the cosmetic injectable consultation.
Cutting-edge Rejuvenation: Injectables + Energy Devices
The subtle results of long-wavelength devices combined with the more dramatic results of injectables can last for years and deliver more natural results than those of injectables alone.
